K. Naber

发表

Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence

B. Ernst, H. Schellekens, F. Scaglione, 2023, Therapeutic Innovation & Regulatory Science.

Antibiotic therapy – rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue

F. Sörgel, K. Naber, Kurt G. Naber, 2003, Andrologia.

Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.

K. Naber, F. Wagenlehner, W. Weidner, 2008, International journal of antimicrobial agents.

Urinary tract infection in adults: research priorities and strategies.

A. Schaeffer, L. Nicolle, J. Krieger, 2001, International journal of antimicrobial agents.

High-performance liquid chromatographic analysis of cefotetan epimers in human plasma and urine.

K. Naber, H. Grobecker, F. Kees, 1984, Journal of chromatography.

EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).

F. Selvaggi, K. Naber, T. Bjerklund-Johansen, 2001, European urology.

Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology.

W. Schneider-Brachert, N. Lehn, K. Naber, 2000, International journal of antimicrobial agents.

[European and Asian guidelines on management and prevention of catheter-associated urinary tract infections].

P. Tambyah, T. Matsumoto, T. B. Bjerklund Johansen, 2008, Urologiia.

Therapeutic challenges of urosepsis

F. Wagenlehner, W. Weidner, A. Pilatz, 2008, European journal of clinical investigation.

Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women.

K. Naber, M. Melekos, E. Gerharz, 1997, The Journal of urology.

[Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline].

S. Schmidt, K. Naber, E. Hummers, 2017, Der Urologe. Ausg. A.

Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten

K. Naber, F. Wagenlehner, E. Hummers, 2017, Der Urologe.

Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis

K. Naber, R. Redman, R. Redman, 2009, Antimicrobial Agents and Chemotherapy.

Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.

I. James, K. Naber, L. Clarysse, 2004, International journal of antimicrobial agents.

Improved diagnostics of chronic inflammatory prostatitis.

K. Naber, E. Kulchavenya, Khomyakov, 2012, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Current challenges in the treatment of complicated urinary tract infections and prostatitis.

K. Naber, F. Wagenlehner, K. Naber, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pharmacokinetics of the Aminoglycoside Antibiotic Tobramycin in Humans

K. Naber, P. Madsen, S. Westenfelder, 1973, Antimicrobial Agents and Chemotherapy.

Linguistic and Clinical Validation of the Tajik Acute Cystitis Symptom Score for Diagnosis and Patient-Reported Outcome in Acute Uncomplicated Cystitis

F. Wagenlehner, A. Pilatz, J. Alidjanov, 2023, Medicina.

Update on biofilm infections in the urinary tract

S. Hultgren, T. B. Bjerklund Johansen, K. Naber, 2012, World Journal of Urology.

Guidelines for the perioperative prophylaxis in urological interventions of the urinary and male genital tract.

K. Naber, A. Hofstetter, K. Bichler, 2001, International journal of antimicrobial agents.

Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.

K. Naber, F. Wagenlehner, S. Schinzel, 2005, European urology.

Which fluoroquinolones are suitable for the treatment of urinary tract infections?

K. Naber, K. Naber, 2001, International journal of antimicrobial agents.

EAU Guidelines for the Management of Urinary and Male Genital Tract Infections1

F. Selvaggi, K. Naber, T. Bjerklund-Johansen, 2001, European Urology.

The importance of the pressure in the prostatic fossa and absorption of irrigating fluid during transurethral resection of the prostate.

K. Naber, P. Madsen, K. Naber, 1973, The Journal of urology.